Trademark: 86656969
Word
QIAGEN GENEREAD SMCOUNTER
Status
Dead
Status Code
606
Status Date
Monday, February 26, 2018
Serial Number
86656969
Mark Type
4000
Filing Date
Tuesday, June 9, 2015
Published for Opposition
Tuesday, May 31, 2016
Abandoned Date
Monday, February 26, 2018

Trademark Owner History
QIAGEN Sciences, LLC - Owner At Publication

Classifications
1 Diagnostic preparations for scientific or research use, not for human medicine and veterinary medicine purposes; reagents and solvents for scientific or research use not for human medical and veterinary purposes, namely, for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of nucleic acid compounds, protein assays and chemical reagents for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material, all for scientific or research use, other than human medicine and veterinary medicine purposes
5 Diagnostic preparations for medical and veterinary use; products for human medicine and veterinary medicine purposes, namely, diagnostic preparations, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; chemical biochemical and biotechnological products all for human medicine and veterinary medicine purposes, namely, reagents and solvents, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits consisting primarily of nucleic acid compounds, protein assays and chemical reagents for human medicine or veterinary medicine diagnostic purposes, namely, for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material
9 Scientific apparatuses, instruments and equipment, namely, optical apparatuses and instruments for laboratory purposes, namely, microscopes, calculating machines, electrical and electronic apparatuses and instruments, namely, sequencers and sequencing machines for research and analysis purposes in the field of molecular biology; laboratory equipment, measuring apparatuses and instruments, namely, robot manipulators, laboratory consumable dispensers, laboratory sample conditioners, namely, incubators, stirrers, mixers, dispensers, aspirators; laboratory and measuring apparatuses and instruments, namely, filter systems for laboratory purposes, fluid sample ultrafiltration devices and apparatuses, fluid sample ultrafiltration membranes, chromatography apparatuses and instruments, ion exchanger apparatuses and instruments, laboratory nucleic acid polymer oligonucleotide concentrator devices; scientific apparatuses and instruments being laboratory equipment and single-use laboratory articles, namely, laboratory apparatuses for the processing of fluid samples, namely, apparatuses for dosing, transferring, mixing, tempering, concentrating, homogenizing and filtering of sample liquids and reagents for medical and veterinary medical diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for labeling, separation, isolation, reproduction and the purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material
42 Scientific and technological services, namely, research and development in the fields of medical diagnostic testing, cancer treatment and diagnosis, treatment and diagnosis of viral and bacterial mediated diseases, treatment and diagnosis of diseases of the blood, treatment and diagnosis of diseases of the skin, treatment and diagnosis of diseases of the brain, treatment and diagnosis of diseases of the heart, treatment and diagnosis of diseases of the liver, treatment and diagnosis of diseases of the lungs; as well as design services, namely, work on and evaluation of chemical syntheses, namely, the synthesis of oligonucleotides, polynucleotides and proteins

Trademark Events
Feb 26, 2018
Abandonment Notice Mailed - No Use Statement Filed
Feb 26, 2018
Abandonment - No Use Statement Filed
Jun 13, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 9, 2017
Extension 2 Granted
Jun 9, 2017
Extension 2 Filed
Jun 9, 2017
Teas Extension Received
Nov 4, 2016
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2016
Extension 1 Granted
Nov 2, 2016
Extension 1 Filed
Nov 2, 2016
Teas Extension Received
Jul 26, 2016
Noa E-Mailed - Sou Required From Applicant
May 31, 2016
Official Gazette Publication Confirmation E-Mailed
May 31, 2016
Published For Opposition
May 11, 2016
Notification Of Notice Of Publication E-Mailed
Apr 21, 2016
Approved For Pub - Principal Register
Mar 24, 2016
Teas/Email Correspondence Entered
Mar 23, 2016
Correspondence Received In Law Office
Mar 23, 2016
Teas Response To Office Action Received
Sep 24, 2015
Notification Of Non-Final Action E-Mailed
Sep 24, 2015
Non-Final Action E-Mailed
Sep 24, 2015
Non-Final Action Written
Sep 17, 2015
Assigned To Examiner
Jun 12, 2015
New Application Office Supplied Data Entered In Tram
Jun 12, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24